According to Abiomed's latest financial reports the company's current earnings (TTM) are $0.25 B. In 2021 the company made an earning of $0.18 B a decrease over its 2020 earnings that were of $0.25 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $0.19 B | 0.67% |
2021 | $0.18 B | -25.49% |
2020 | $0.25 B | -19.62% |
2019 | $0.31 B | 48.14% |
2018 | $0.21 B | 51% |
2017 | $0.14 B | 71.85% |
2016 | $0.08 B | 41.79% |
2015 | $0.05 B | 187.69% |
2014 | $0.02 B | 126.26% |
2013 | $8.9 M | -43.08% |
2012 | $0.01 B | -917.66% |
2011 | -$1.92 M | -76.42% |
2010 | -$8.12 M | -70.88% |
2009 | -$0.03 B | -25.56% |
2008 | -$0.04 B | 18.05% |
2007 | -$0.04 B | 28.07% |
2006 | -$0.03 B | 88.34% |
2005 | -$0.02 B | 193.13% |
2004 | -$4.49 M | -62.24% |
2003 | -$0.02 B | -35.9% |
2002 | -$0.02 B | -33.54% |
2001 | -$0.03 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Boston Scientific BSX | $1.44 B | 462.90% | ๐บ๐ธ USA |
![]() Teleflex TFX | $0.61 B | 140.00% | ๐บ๐ธ USA |
![]() AtriCure ATRC | $0.05 B | -77.84% | ๐บ๐ธ USA |